ADMA BIOLOGICS, INC. Increase (Decrease) in Restricted Cash
ADMA BIOLOGICS, INC. (ADMA) reported Increase (Decrease) in Restricted Cash of $115.04 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2013-03-06
- ADMA BIOLOGICS, INC. increase (decrease) in restricted cash for fiscal 2012 was $115.04K.
- ADMA BIOLOGICS, INC. increase (decrease) in restricted cash for fiscal 2011 was -$90.00K.
| Period end | Increase (Decrease) in Restricted Cash 12 month |
|---|---|
| 2012-12-31 | $115.04K 10-K · filed 2013-03-06 |
| 2011-12-31 | -$90.00K 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |